ORIGINAL CONTRIBUTION. Basal Ganglia Metabolite Abnormalities in Minor Motor Disorders Associated With Human Immunodeficiency Virus Type 1
|
|
- Nelson Nicholson
- 5 years ago
- Views:
Transcription
1 ORIGINAL CONTRIBUTION Basal Ganglia Metabolite Abnormalities in Minor Motor Disorders Associated With Human Immunodeficiency Virus Type 1 Hans-Jürgen von Giesen, MD; Hans-Jörg Wittsack, PhD; Frank Wenserski, MD; Hubertus Köller, MD; Harald Hefter, MD, PhD; Gabriele Arendt, MD Background: Minor motor disorders (MMDs) associated with human immunodeficiency virus type 1 (HIV-1) predict HIV-1 dementia and death. Little is known about the time course and neuropathologic mechanisms of HIV-1 MMDs. Objective: To investigate the relationship between HIV-1 MMDs, as assessed by psychomotor speed, and metabolic alterations in the basal ganglia, as detected by proton magnetic resonance spectroscopy. Patients and Methods: A total of 32 HIV-1 seropositive patients (10 with no MMD, 8 with incipient MMD, and 14 with sustained MMD, assessed through electrophysiologic testing of psychomotor speed including contraction times; 29 treated with highly active antiretroviral therapy) and 14 HIV-1 seronegative control subjects were examined for cerebral metabolite abnormalities in the basal ganglia by means of magnetic resonance spectroscopy. Results: The 3 patient groups showed significantly different ratios of myoinositol/creatine (P=.02) in the basal ganglia. Whereas patients with no MMD or incipient MMD showed normal ratios, patients with sustained MMD showed higher values for myoinositol/creatine as a sign of glial proliferation. No differences in N-acetyl compounds, indicative of neuronal loss, were found. Conclusion: Whereas metabolic alterations in the basal ganglia were not detected in patients with incipient HIV-1 MMD, patients with sustained HIV-1 MMD did have significantly altered metabolic spectra indicative of glial proliferation. Arch Neurol. 2001;58: From the Departments of Neurology (Drs von Giesen, Köller, Hefter, and Arendt) and Diagnostic Radiology (Drs Wittsack and Wenserski), Heinrich Heine University, Düsseldorf, Germany. THE COGNITIVE-MOTOR complex associated with human immunodeficiency virus type 1 (HIV-1) 1 is the most important manifestation of HIV-1 in the brain and encompasses both clinically manifest dementia and a milder preclinical form: minor cognitive-motor disorders. These minor disorders can be verified by neuropsychological testing, eg, by testing psychomotor speed. 1 Although different test paradigms have been used, both European 2 and large American 3 studies have demonstrated that pathologic psychomotor slowing predicts progression in HIV-1 associated brain disease toward dementia and death. Reliable quantitative assessment and long-term monitoring of HIV- 1 associated minor motor disorders (MMDs) are therefore essential for each patient to determine the individual prognosis. It is important to learn more about the time course of HIV-1 MMDs, their possible reversibility or irreversibility within certain time windows. This is particularly important because, at this stage of the disease, HIV-1 may affect various biochemical pathways both directly and indirectly through immune-mediated inflammatory pathomechanisms before structural brain damage resulting in irreversible neuronal loss becomes manifest. To assess the relationship between the functional tests defining MMD and possible biochemical alterations, we used proton ( 1 H) magnetic resonance spectroscopy (MRS). The use of MRS can describe biochemical alterations in inflammatory and infectious brain disease 4 and has been shown to sensitively detect such alterations in early stages of HIV-1 associated brain disease. 5-7 Specifically, MRS was used to detect changes indicating glial proliferation. For this purpose, we chose the myoinositol (mi) creatine (Cr) ratio, which is known to increase with gliosis. 8 We recently described early changes of brain metabolism as assessed by positron emission tomography in the basal ganglia. 9 Since the basal ganglia are particularly involved in the neuropathogenesis of 1281
2 SUBJECTS AND METHODS PATIENTS AND CONTROL SUBJECTS Fourteen HIV-1 seronegative healthy volunteers (all white men; mean±sd age, 33.6±6.5 years) served as controls. Thirty-three HIV-1 seropositive subjects (all white homosexual men with no history of substance abuse) were recruited from the Neuro-AIDS outpatient clinic. Written informed consent was obtained in accordance with guidelines of the Declaration of Human Rights, Helsinki The study was approved by the local ethics committee. Demographic data for all subjects are shown in Table 1. None of the patients had evidence of HIV-1 associated myelopathy or HIV-1 associated peripheral polyneuropathy, none had ever had cerebral lymphoma or cerebral opportunistic infection, and none showed clinical signs of basal ganglia dysfunction. None fulfilled the clinical criteria for HIV- 1 associated dementia 1 at the time of MRS, and none subsequently developed HIV-1 associated dementia as of June 30, All patients underwent regular electrophysiologic motor testing every 3 months before and after MRS. Evaluation further included the motor scores of the Unified Parkinson s Disease Rating Scale 16 and the HIV Dementia Scale. 17 MAGNETIC RESONANCE IMAGING Both magnetic resonance (MR) imaging and MRS were performed on a 1.5-T whole-body MR scanner (Siemens Magnetom Vision; Siemens, Erlangen, Germany) between May 25, 1999, and January 18, The following sequences were performed in all patients and controls: axial, coronal, and sagittal T1-weighted fast-low angle shot sequence (repetition time [TR], 300 milliseconds; echo time [TE], 6 milliseconds; 20 slices, 6 mm; matrix, ; field of view [FOV], 230 mm), axial T2-weighted turbogradient spin echo sequence (TR, 7040 milliseconds; TE, 115 milliseconds; 20 slices, 6 mm; matrix, ; FOV, 230 mm), axial fluid-attenuated inversion recovery sequence (TR, 9000 milliseconds; TE, 105 milliseconds; inversion time, 2200 milliseconds; 18 slices, 6 mm; matrix, ; FOV, 230 mm), and coronal T1-weighted spin echo sequence after application of intravenous gadopentetate dimeglumine (TR, 560 milliseconds; TE, 17 milliseconds; 20 slices, 6 mm; matrix, ; FOV, 230 mm). Structural abnormalities led to exclusion. All MR images were evaluated qualitatively by an experienced neuroradiologist (F.W.) who was blind to the clinical status of patients and controls. MAGNETIC RESONANCE SPECTROSCOPY On the basis of the 3 orthogonal T1-weighted MR images, the target volumes for 1 H-MRS were planned for the region of basal ganglia. The size of volumes was 2 2 2cm 3 (Figure), leading to a sufficient signal-to-noise ratio within a reasonable measurement time. Volumes were placed as demonstrated in the Figure, including the striatum and parts of the thalamus. This placement includes regions of less interest than the striatum; however, another placement would necessarily have included parts of the ventricle system, leading to systematic difficulties in the interpretation of data because of an inhomogeneous sampling volume including not only gray and white matter but also cerebrospinal fluid. Spectroscopic data were acquired by a stimulated echo acquisition mode 18 sequence using a TE of 20 milliseconds, a TR of 1500 milliseconds, and 256 acquisitions. The spectral line widths were 8 to 9 Hz for the water resonance resulting from the preceding shimming procedure. Water suppression was performed with a frequency- HIV-1 MMDs and dementia, 10 our study was designed to look for changes in these structures. Broader background knowledge would allow a more rational use of the prophylactic 11 as well as the therapeutic effects of antiretroviral therapy. RESULTS Demographic data are shown in Table 1. Patient groups did not differ with regard to age, duration of HIV-1 seropositivity, or CD4 cell counts. Acquired immunodeficiency syndrome stages prevailed in all groups; 29 patients were receiving treatment with highly active antiretroviral therapy (HAART). The HIV Dementia Scale score did not differ between groups. Values ranged between the reported scores for asymptomatic HIVseropositive patients (14.1) and nondemented acquired immunodeficiency syndrome defined patients (12.8). 17 In accord with the group definitions, the Unified Parkinson s Disease Rating Scale motor score in group 3 was significantly higher than in group 1 (Fisher PLSD, P=.009). The CT values defined the groups. Whereas patients in groups 2 and 3 showed significantly longer CTs than patients in group 1 (ANOVA, P.001; Fisher PLSD, P.001 for groups 2 and 3 vs group 1), the changes of CTs for the worse (negative value of difference) were most marked in group 2 (ANOVA, P=.03; Fisher PLSD, P=.08 vs group 3 and P=.008 vs group 1). In accord with the definition criteria, pathologic CTs had been present longest in group 3 (median, 21 months), only for a short time in group 2 (median, 3 months), and not at all in group 1. Routine MR imaging sequences showed no regional structural abnormalities and no pathologic contrast enhancement. Fifteen patients, evenly distributed among the groups, showed a mild degree of brain atrophy. Two patients in group 1 and 1 patient in group 3 showed nonspecific white matter lesions. In a first step of the analysis, we asked whether HIV- 1 seropositive but nondemented patients as a whole showed metabolic abnormalities. Patients and control subjects were therefore compared (Table 2). On a group statistical level, no significant metabolic differences between HIV-1 seronegative control subjects and HIV-1 seropositive but neurologically asymptomatic patients were found. No significant differences between right and left basal ganglia samples were detected. In a second step of the analysis, we were interested in the question of whether HIV-1 seropositive patients with and without HIV-1 associated MMDs would differ metabolically. Therefore, patient groups 1, 2, and 3 were 1282
3 selective 90 prepulse with gaussian pulse shape. The spectroscopic data were transferred to a workstation. The residual signal of the suppressed water was subtracted by means of the Hankel singular value decomposition algorithm. 19 An exponential line broadening of 1 Hz was performed. For the determination of the signal intensities of the different metabolites, spectra were fitted by means of the time domain fitting algorithm VARPRO (VARiable PROjection method) 20,21 and an MR user interface tool kit. 22 The evaluation of short echo in vivo spectra is difficult because of overlapping resonances of the metabolites and also because of possible background problems. 23,24 To obtain stable results for the individual signal intensities of the different metabolites, we used the technique of time domain fitting with prior knowledge for the different resonances. 25 The signal intensities determined for the following peaks were relevant for the statistical analysis: glutamine/glutamate, 3.65 to 3.80 ppm; mi, 3.54 ppm; choline-containing compounds (Cho), 3.20 ppm; Cr and phosphocreatine (Cr/PCr), 3.00 ppm; and N-acetylaspartate (NAA), 2.00 ppm (Figure). Only metabolite ratios were analyzed, since determination of absolute metabolite concentrations was impossible in our department for technical reasons. ELECTROPHYSIOLOGIC MOTOR TESTING Electrophysiologic assessment of psychomotor speed included the analysis of most rapid voluntary isometric index finger extensions. The variables measured in this context were simple reaction time, ie, the time span between a short go signal and the onset of contraction, and contraction time (CT), ie, the time span between the onset and peak force of the contraction (for methodologic details see Arendt et al 26 ). Normal values for 98 HIV-1 seronegative controls have been published. 27 The CTs were rated pathologic if at least the value of one hand fell outside the mean +2 SDs. Patients were separated into 3 groups. Group 1 consisted of patients who had never shown pathologic CT values. Mean±SD duration of asymptomatic follow-up before MRS was 49.3±34.6 months. These patients were thus completely asymptomatic. Group 2 consisted of patients who showed pathologic CTs for the first time during their individual follow-up. These patients were considered to have incipient HIV-1 MMDs. Group 3 included patients who showed repeated and thus sustained pathologic prolongations of CTs for a mean period of 28.4±24.2 months (significantly longer than groups 1 and 2; Fisher protected least significant difference [PLSD], P.01). These patients would fulfil the criteria for HIV-1 MMD. If CT was pathologic for both hands, we chose the more marked prolongation and performed MRS for the contralateral basal ganglia. There was no difference in the distribution between right and left basal ganglia sampled between the groups (group 1: right, n=5; left, n=5; group 2: right, n=5; left, n=3; group 3: right, n=8; left, n=6). STATISTICS Statistical analysis was performed with the commercially available software package Statview (Version ; SAS Institute Inc, Cary, NC, 1998). Analysis of variance (ANOVA) was performed to evaluate differences in basal ganglia metabolite concentrations and metabolite ratios between the different groups. Post hoc analyses with Fisher PLSD were used to determine the significance of differences between any 2 groups. To investigate possible relationships between variables, we performed regression analyses using the metabolite ratios and differences in CD4 cell counts, log plasma viral load, and CT values for 6-month periods: (1) the 6 months before MRS, (2) from 3 months before to 3 months after MRS, and (3) from MRS to 6 months thereafter. compared (Table 3). ANOVA showed significant differences between groups for the mi/cr ratio. Patients with sustained pathologic psychomotor testing (group 3) showed significantly higher mi/cr ratios than patients who showed slowing for the first time (group 2) (Fisher PLSD, P=.01) and patients with consistently normal psychomotor speed (group 1) (Fisher PLSD, P=.03). When patients in group 3 were compared with patients in groups 1 and 2 together, the difference remained significant (unpaired t test, 0.57±0.07 vs 0.49±0.09; P=.007). Although the mean values of all groups were within the normal range, patients in group 3 ranked significantly higher in the Mann-Whitney test (P=.01; mean rank for groups 1+2, 12.7; mean rank for group 3, 21.4). Unified Parkinson s Disease Rating Scale scores did not correlate with mi/cr ratios. No significant changes for the other ratios were observed among the 3 groups. No significant correlations (P.05) between metabolite ratios and differences in CD4 cell counts, log plasma viral load, and CT values were detected. COMMENT The present study was designed to answer the question of whether (and, if so, at what time) MRS can detect metabolic abnormalities constituting a possible pathophysiologic and functional correlate of HIV-1 associated MMDs. So far, most studies have applied MRS to the examination of HIV-1 seropositive patients with manifest dementia The MRS spectra in demented patients were characterized by reduced levels of NAA and increased levels of choline in white matter regions. 28,33 Metabolic abnormalities were more marked in more advanced stages of dementia. 28 A Cho increase appeared before the NAA decrease. 34 According to these findings, the NAA/Cr and Cho/Cr ratios have been found to be decreased and increased, respectively, in demented patients. 32,35 Whereas NAA/Cr and NAA/Cho ratios were reduced in cognitively impaired patients 30 in the centrum semiovale and mesial cortex, no significant NAA differences could be detected in the basal ganglia. 31 Since NAA is a marker for mature neurons, 36 a decrease in NAA in demented patients has been interpreted as a sign of neuronal loss or damage in relatively late stages of HIV-1 associated brain damage. However, focusing on earlier and subclinical stages of the disease may help to better treat or prevent HIV-1 cognitive-motor complex rather than focusing on manifest disease stages when neuronal death is already present and possibly extensive. 37 One study that included both demented and asymptomatic patients found 1283
4 Table 1. Demographic Data of All HIV-1 Seropositive Patients* Group 1 (n = 10) Group 2 (n = 8) Group 3 (n = 14) Age, y 43.1 ± ± ± 10.4 Duration of HIV-1 seropositivity, y 7.8 ± ± ± 4.5 CDC stages at MRS, No. Non-AIDS stages AIDS stages Antiretroviral therapy at time of MRS, No. No antiretroviral therapy HAART CD4 cell count, cells/µl 553 ± ± ± 205 HIV-1 plasma viral load at MRS, No. 2 log (copies/ml) to 4 log (copies/ml) log (copies/ml) Not available HIV dementia scale score 14.1 ± ± ± 2.9 UPDRS motor score (mean) at MRS CT at MRS, ms ± ± ± 30.1 Change in CT 6 mo before MRS, ms 2.4 ± ± ± 36.5 Duration of pathologic CT before MRS, mo ± ± 24.2 Duration of follow-up before first pathologic CT, mo 49.3 ± ± ± 3.7 Duration of follow-up after MRS, mo 9.0 ± ± ± 1.7 *Values are given as mean ± SD unless otherwise specified. Group 1 never had pathologic psychomotor slowing; group 2 had it for the first time; and in group 3 it was sustained. HIV-1 indicates human immunodeficiency virus type 1; CDC, Centers for Disease Control and Prevention; MRS, magnetic resonance spectroscopy; AIDS, acquired immunodeficiency syndrome; HAART, highly active antiretroviral therapy; UPDRS, Unified Parkinson s Disease Rating Scale; and CT, contraction time. A Difference Reconstructed Spectrum Original Spectrum Glx mi Cho Cr/PCr NAA Signal Intensity, ppm A, Spectrum of the basal ganglia region of a normal subject. Glx indicates glutamine/glutamate; mi, myoinositol; Cho, choline-containing compounds; Cr/PCr, creatine and phosphocreatine; and NAA, N-acetylaspartate. B, Localization of the spectroscopic volume. B NAA/Cr decreases and both mi/cr and Cho/Cr increases in both white and gray matter in demented patients, 29 but only slight changes in the NAA/Cr and mi/cr peaks in asymptomatic patients. We have therefore defined the groups in this study according to the very first, subtle, but electrophysiologically detectable manifestation of psychomotor slowing, which is highly predictive of the later development of HIV-1 associated dementia. 2,3 The psychomotor test allows us to distinguish between patients who are functionally completely normal and those who show either incipient or sustained functional damage. Naturally, the approach bears the risk that patients are examined at such an early point during the course of the disease that minor metabolic abnormalities may escape detection. To further improve the chances of detecting very early signs of HIV-1 associated central nervous system dysfunction, we chose the basal ganglia as the region of interest. We recently showed that psychomotor slowing in HIV-1 seropositive patients is associated with metabolic disturbances in the basal ganglia. 9 There is unequivocal evidence that the basal ganglia play a pivotal role in HIV-1 infection of the brain. 10,38 Because we selected our patients for this study according to strict criteria, they did not, as a whole, show any notable metabolic abnormalities as detected by MRS. However, after separating them into the herein-defined groups, we did find significant differences. Although all mean values lie within the normal range, patients in group 3 had significantly higher mi/cr ratios than those of groups 1 and 2. The size and placement of regions of interest in our patients may also account for the relative variability of data despite the significant but relatively small differences between groups. Focusing exclusively on the striatum (which was impossible in our experimental setting) might have led to more significant differences. However, the fact that we can detect significant differences between the electrophysiologically defined groups in this study makes the explanation we suggest even more probable. Chang and coworkers 6 recently described an increased Cho/Cr ratio in the midfrontal white matter and 1284
5 Table 2. Group Statistical Comparison Between Patients and Control Subjects* MRS Variable HIV-1 Seronegative Control Subjects (n = 14) HIV-1 Seropositive Patients (Groups 1-3) (n = 32) P NAA/Cr 1.48 ± ± Cho/Cr 0.73 ± ± mi/cr 0.52 ± ± Glx/Cr 0.80 ± ± NAA/Cho 2.07 ± ± mi/cho 0.74 ± ± *Values are mean ± SD. MRS indicates magnetic resonance spectroscopy; HIV-1, human immunodeficiency virus type 1; NAA, N-acetylaspartate; Cr, creatine; Cho, choline-containing compounds; mi, myoinositol; and Glx, glutamine/glutamate. Unpaired test. No P value was significant. Table 3. Group Statistical Comparison Among Patient Groups 1 to 3* MRS Variable Group 1 Group 2 Group 3 P NAA/Cr 1.55 ± ± ± Cho/Cr 0.72 ± ± ± mi/cr 0.50 ± ± ± Glx/Cr 0.72 ± ± ± NAA/Cho 2.18 ± ± ± mi/cho 0.70 ± ± ± *Values are mean ± SD. See footnote to Table 1 for explanation of groups and first footnote to Table 2 for explanation of abbreviations. Analysis of variance. P.05 was considered significant. in the basal ganglia as well as an elevated mi/cr ratio and mi concentration in the basal ganglia. Importantly, these changes normalized with HAART. Most of our patients were also treated with HAART, which may explain the relatively small differences between our groups. Untreated patients may show more significant differences. Higher Cho concentrations were also found in subcortical brain regions early in HIV-1 disease when individuals were clinically and neuropsychologically asymptomatic, whereas low NAA levels were only found in subcortical brain regions in individuals with severe neuropsychological impairments. 7 Conversely, MMDs are not associated with a decrease in NAA. 5 We conclude that sustained HIV-1 MMDs even with HAART may be associated with altered mi/cr ratios. Myoinositol has been identified as a glia-specific marker that may participate in the osmoregulatory system in astrocytes. 8 Disturbances in astrocyte function may therefore play an important role in the pathogenesis of sustained HIV-1 MMDs. Interestingly, another MRS study of patients without HIV-1 associated dementia showed a statistically significant increase in mi/cr ratios in white matter compared with normal control subjects. 39 That group may well have consisted of patients with pathologic psychomotor slowing. In contrast, the demented group in that study showed almost normal levels of mi/cr in both gray and white matter and a significant decrease in NAA/Cr in gray matter compared with both the control subjects and patients without dementia. 39 Highly active antiretroviral therapy has been found to improve metabolic dysregulation. 6 Psychomotor slowing may also respond to antiretroviral therapy. 12,14 Since all but 3 of our patients received HAART, therapy may account for the relatively small degree of differences between our patient groups. However, if our finding of only slight metabolic disturbances is due to the therapeutic effect of HAART, it would imply that electrophysiologic motor testing may be more sensitive than MRS in detecting early signs of HIV-1 associated central nervous system disease at least in the basal ganglia. Other regions of interest including the frontal white matter must therefore be examined. Although the mean CD4 cell counts in our patients were within expected asymptomatic ranges, the groups did differ with regard to CT values and mi/cr ratios in the basal ganglia. These findings are in good agreement with those of Price and coworkers, 13 who described that CD4 cell counts, HIV-1 RNA plasma levels, and neurologic impairment are independent predictors of mortality. Hypothetically, 9 the course of HIV-1 MMDs could begin with increased cerebral blood flow followed by functional deficits. The patients in our group 2 were most likely in this pathogenetic phase. More sustained pathologic psychomotor slowing (group 3) would be accompanied by progressive gliosis and more marked metabolic dysregulation. A final hypometabolic phase with neuronal loss and clinical manifestation of HIV-1 dementia would follow. Obviously, such a hypothesis stresses the urgent need for continuous follow-up examinations of patients, especially to determine the points in individual pathogenesis that are therapeutically accessible. Accepted for publication January 8, We thank Kristina Rascher, MD, for helpful linguistic advice and Erika Rädisch for skillful technical assistance. Corresponding author and reprints: Hans-Jürgen von Giesen, MD, Department of Neurology, Heinrich-Heine- Universität, Düsseldorf, Postfach , D Düsseldorf, Germany ( giesenhj@uni-duesseldorf.de). REFERENCES 1. Janssen RS, Cornblath DR, Epstein LG, et al. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virustype 1 (HIV-1) infection. Neurology. 1991;41: Arendt G, Hefter H, Hilperath F, von Giesen HJ, Strohmeyer G, Freund HJ. Motor analysis predicts progression in HIV-associated brain disease. J Neurol Sci. 1994; 123: Sacktor NC, Bacellar H, Hoover DR, et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol. 1996;2: Cecil KM, Lenkinski RE. Proton MR spectroscopy in inflammatory and infectious brain disorders. Neuroimaging Clin North Am. 1998;8: Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology. 1999;52: Chang L, Ernst T, Leonido-Yee M, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology. 1999; 53: Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology. 1999;52: Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci. 1993;15:
6 9. von Giesen HJ, Antke C, Hefter H, Wenserski F, Seitz RJ, Arendt G. Potential time course of human immunodeficiency virus type 1 associated minor motor deficits: electrophysiologic and positron emission tomography findings. Arch Neurol. 2000;57: Berger JR, Arendt G. HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol. 2000;14: von Giesen HJ, Hefter H, Jablonowski H, Arendt G. HAART is neuroprophylactic in HIV-1 infection. J Acquir Immune Defic Syndr. 2000;23: Arendt G, Hefter H, Buescher L, Hilperath F, Elsing C, Freund HJ. Improvement of motor performance of HIV-positive patients under AZT therapy. Neurology. 1992;42: Price RW, Yiannoutsos CT, Clifford DB, et al, for the AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS. 1999;13: Sacktor NC, Lyles RH, Skolasky RL, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men: Multicenter AIDS Cohort Study (MACS). Neurology. 1999;52: Tozzi V, Balestra P, Galgani S, et al. Positive and sustained effects of highly active antiretroviral therapy on HIV-1 associated neurocognitive impairment. AIDS. 1999;13: Fahn S, Elton R, and members of the UPDRS Development Committee. Unified Parkinson s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson s Disease. Florham Park, NJ: Macmillan Health Care Information; 1987: , Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8: Frahm J, Merboldt KD, Hänicke W, Haase A. Stimulated echo imaging. J Magn Reson. 1985;64: van den Boogaart A, van Ormondt D, Pijnappel WWF, de Beer R, Als-Korpela M. Removal of water resonances from 1 H magnetic resonance spectra. In: McWhirter JG, ed. Mathematics in Signal Processing. Oxford, England: Clarendon Press; 1994: van der Veen JW, de Beer R, Luyten PR, van Ormondt D. Accurate quantification of in vivo 31 P NMR signals using the variable projection method and prior knowledge. Magn Reson Med. 1988;6: de Beer R, van den Boogaart A, van Ormondt D, et al. Application of timedomain fitting in the quantification of in vivo 1 H spectroscopic imaging data sets. NMR Biomed. 1992;5: van den Boogaart A. MRUI Manual, Version 96.3: A User s Guide to the Magnetic Resonance User Interface Software Package. Leuven, Belgium: A van den Boogaart; De Beer R, van den Boogaart A, Cady E, et al. Absolute metabolite quantification by in vivo NMR spectroscopy, V: multicentre quantitative data analysis trial on the overlapping background problem. Magn Reson Imaging. 1998;16: Decanniere C, van Hecke P, Vanstapel F, et al. Evaluation of signal processing methods for the quantification of strongly overlapping peaks in 31 P NMR spectra. J Magn Reson B. 1994;105: De Beer R, Bachert-Baumann P, Bovee WM, et al. Quality assessment in in vivo NMR spectroscopy, VI: multicentre quantification of MRS test signals. Magn Reson Imaging. 1995;13: Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund HJ. Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. J Neurol. 1990;237: von Giesen HJ, Hefter H, Roick H, Mauss S, Arendt G. HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers. J Neurol. 1994; 242: Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology. 1995;195: Laubenberger J, Häussinger D, Bayer S, et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology. 1996;199: Meyerhoff DJ, MacKay S, Bachman L, et al. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus seropositive individuals: in vivo 1 H magnetic resonance spectroscopic imaging. Neurology. 1993;43: Meyerhoff DJ, Weiner MW, Fein G. Deep gray matter structures in HIV infection: a proton MR spectroscopic study. Am J Neuroradiol. 1996;17: Moller HE, Vermathen P, Lentschig MG, et al. Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging. 1999;9: Chong WK, Sweeney B, Wilkinson ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology. 1993;188: Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG. Brain cholinecontaining compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology. 1996;46: Marcus CD, Taylor-Robinson SD, Sargentoni J, et al. 1 H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities. Metab Brain Dis. 1998;13: Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13: Goodkin K, Wilkie FL, Concha M, et al. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection: neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Neuroimaging Clin North Am. 1997;7: Berger JR, Nath A. HIV dementia and the basal ganglia. Intervirology. 1997;40: Lopez-Villegas D, Lenkinski RE, Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad SciUSA. 1997;94:
HIV Dementia Scale and Psychomotor Slowing The Best Methods in Screening for Neuro-AIDS
HIV Dementia Scale and Psychomotor Slowing The Best Methods in Screening for Neuro-AIDS Hans-Jürgen von Giesen, M.D. Bernhard A. Haslinger, M.D. Simone Rohe Hubertus Köller, M.D. Gabriele Arendt, M.D.
More informationAnalysis of metabolic changes of brain in HIV-1 seropositive patients with proton magnetic resonance spectroscopy
Signature: Pol J Radiol, 2010; 75(2): 27-32 ORIGINAL ARTICLE Received: 2010.03.25 Accepted: 2010.04.06 Analysis of metabolic changes of brain in HIV-1 seropositive patients with proton magnetic resonance
More informationFig. 1. Localized single voxel proton MR spectroscopy was performed along the long axis of right hippocampus after extension of patient s head to
125 A B C Fig. 1. Localized single voxel proton MR spectroscopy was performed along the long axis of right hippocampus after extension of patient s head to obtain entire dimension of the hippocampal body.
More informationGood Neurocognitive Performance Measured by the International HIV Dementia Scale in Early HIV-1 Infection
BRIEF REPORT: CLINICAL SCIENCE Good Neurocognitive Performance Measured by the International HIV Dementia Scale in Early HIV-1 Infection Gustavo D. Lopardo, MD,* Emiliano Bissio, MD,* María del C. Iannella,*
More informationJosé A Mendes-Ribeiro, Raquel Soares, Fernanda Simões-Ribeiro, M Luiza Guimarães
58 Neurophysiology Unit J A Mendes-Ribeiro M L Guimarães Department of Neurology and Neurosurgery, Hospital S João, Porto, Portugal F Simões-Ribeiro Magnetic Resonance Unit, IPO, Porto, Portugal R Soares
More informationComparison of 1.5T and 3T 1 H MR Spectroscopy for Human Brain Tumors
Comparison of 1.5T and 3T 1 H MR Spectroscopy for Human Brain Tumors Ji-hoon Kim, MD 1 Kee-Hyun Chang, MD 2-4 Dong Gyu Na, MD 2 In Chan Song, PhD 2,3 Seung Ja Kim, MD 2 Bae Ju Kwon, MD 2 Moon Hee Han,
More informationUsefulness of Single Voxel Proton MR Spectroscopy in the Evaluation of Hippocampal Sclerosis
Usefulness of Single Voxel Proton MR Spectroscopy in the Evaluation of Hippocampal Sclerosis 1, 2, 3 Kee-Hyun Chang, MD Hong Dae Kim, MD 1 Sun-Won Park, MD 1 In Chan Song, PhD 2 In Kyu Yu, MD 1 1, 2, 3
More informationEffects of Contrast Material on Single-volume Proton MR Spectroscopy
AJNR Am J Neuroradiol 21:1084 1089, June/July 2000 Effects of Contrast Material on Single-volume Proton MR Spectroscopy J. Keith Smith, Lester Kwock, and Mauricio Castillo BACKGROUND AND PURPOSE: Administration
More informationReference Values for Long Echo Time MR Spectroscopy in Healthy Adults
AJNR Am J Neuroradiol 26:1439 1445, June/July 2005 Reference Values for Long Echo Time MR Spectroscopy in Healthy Adults Yair Safriel, MarlyAnne Pol-Rodriguez, Edward J. Novotny, Douglas L. Rothman, and
More informationProton Magnetic Resonance Spectroscopy
1432/Cap.10/2b 12-11-2001 16:55 Pagina 3 Chapter 10 Proton Magnetic Resonance Spectroscopy Z. CARAMANOS, A.C. SANTOS, S.J. FRANCIS, S. NARAYANAN, D. PELLETIER, D.L. ARNOLD Introduction Primary Progressive
More informationCONTRACTING ORGANIZATION: Johns Hopkins University School of Medicine Baltimore, MD
AD Award Number: DAMD17-01-1-0713 TITLE: Proton MR Spectroscopic Imaging in NF1 PRINCIPAL INVESTIGATOR: Peter B Barker, D.Phil. CONTRACTING ORGANIZATION: Johns Hopkins University School of Medicine Baltimore,
More informationExtraneous Lipid Contamination in Single-Volume Proton MR Spectroscopy: Phantom and Human Studies
Extraneous Lipid Contamination in Single-Volume Proton MR Spectroscopy: Phantom and Human Studies Lester Kwock, Mark A. Brown, and Mauricio Castillo PURPOSE: To determine the degree of extraneous lipid
More informationNeuroradiology of AIDS
Neuroradiology of AIDS Frank Minja,, HMS IV Gillian Lieberman MD September 2002 AIDS 90% of HIV patients have CNS involvement 1 10% of AIDS patients present first with neurological symptoms 2 73-80% of
More informationUniversity of Groningen. Biomarkers in premanifest Huntington's disease van Oostrom, Joost Cornelis Hendricus
University of Groningen Biomarkers in premanifest Huntington's disease van Oostrom, Joost Cornelis Hendricus IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you
More informationLocalized Proton NMR Spectroscopy in Different Regions of the Human Brain in Viva Relaxation Times and
MAGNETIC RESONANCE IN MEDICINE Il,47-63 (1989) Localized Proton NMR Spectroscopy in Different Regions of the Human Brain in Viva Relaxation Times and Concentrations of Cerebral Metabolites J. FRAHM, H.
More informationDeakin Research Online
Deakin Research Online This is the published version: Silberstein, Morry, Lane, Dianne, Dodd, Seetal and Opeskin, Kenneth 2002, Identification of a by-product of nitric oxide synthase activity in human
More informationRemoval of Nuisance Signal from Sparsely Sampled 1 H-MRSI Data Using Physics-based Spectral Bases
Removal of Nuisance Signal from Sparsely Sampled 1 H-MRSI Data Using Physics-based Spectral Bases Qiang Ning, Chao Ma, Fan Lam, Bryan Clifford, Zhi-Pei Liang November 11, 2015 1 Synopsis A novel nuisance
More informationMR Spectroscopic Evaluation of Psychomotor Delay of Unknown Cause in Children
Pediatric Imaging Original Research Koşucu et al. MR Spectroscopy of Psychomotor Delay Pediatric Imaging Original Research Polat Koşucu 1 Sema Erdemli 2 Müjgan Sönmez 3 Sibel Kul 1 Ayşe Aksoy 3 Koşucu
More informationImprovement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors
(2000) 6, 84 ± 88 ã 2000, Inc. www.jneurovirol.com Short Communication Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors Ned Charlton Sacktor*,1, Richard
More informationcontrols. <Conclusions> These data support the hypothesis that JME and FLE involve neuronal dysfunction within the temporal lobe as well as the
A single-voxel spectroscopy study of hippocampal metabolic dysfunction in patients with juvenile myoclonic epilepsy, frontal lobe epilepsy, and psychogenic nonepileptic seizures Epilepsy Center, National
More information(See editorial commentary by Brew, on pages )
HIV/AIDS MAJOR ARTICLE Does Choice of Combination Antiretroviral Therapy (cart) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive, HIV-1 Infected Individuals Commencing cart?
More informationCorrelation of Myo-inositol Levels and Grading of Cerebral Astrocytomas
AJNR Am J Neuroradiol 21:1645 1649, October 2000 Correlation of Myo-inositol Levels and Grading of Cerebral Astrocytomas Mauricio Castillo, J. Keith Smith, and Lester Kwock BACKGROUND AND PURPOSE: In a
More informationProton MR Spectroscopy of the Brain in 14 Patients with Parkinson Disease
Proton MR Spectroscopy of the Brain in 14 Patients with Parkinson Disease Brian C. Bowen, Ronald E. Block, Juan Sanchez-Ramos, Pradip M. Pattany, David A. Lampman, James B. Murdoch, and Robert M. Quencer
More informationUniversity of Groningen. Neuro-imaging of visual field defects Boucard, Christine
University of Groningen Neuro-imaging of visual field defects Boucard, Christine IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationRole of proton magnetic resonance spectroscopy in diagnosis of pilocytic astrocytoma in children
Alexandria Journal of Medicine (2012) 48, 131 137 Alexandria University Faculty of Medicine Alexandria Journal of Medicine www.sciencedirect.com ORIGINAL ARTICLE Role of proton magnetic resonance spectroscopy
More informationStudy of the CNS. Bent O. Kjos' Richard L. Ehman Michael Brant-Zawadzki William M. Kelly David Norman Thomas H. Newton
271 Reproducibility of Relaxation Times and Spin Density Calculated from Routine MR Imaging Sequences: Clinical Study of the CNS Bent O. Kjos' Richard L. Ehman Michael Brant-Zawadzki William M. Kelly David
More informationEffects of Alcohol and HIV Infection on the Central Nervous System. Dieter J. Meyerhoff, Ph.D.
Effects of Alcohol and HIV Infection on the Central Nervous System Dieter J. Meyerhoff, Ph.D. Many people at risk for or infected with the human immunodeficiency virus (HIV) are heavy drinkers. Both HIV
More informationProton MR Spectroscopy of Polymicrogyria and Heterotopia
AJNR Am J Neuroradiol 24:2077 2081, November/December 2003 Proton MR Spectroscopy of Polymicrogyria and Heterotopia Elysa Widjaja, Paul D. Griffiths, and Iain D. Wilkinson BACKGROUND AND PURPOSE: Proton
More informationWhite Matter Disease Induced by High-Dose Chemotherapy: Longitudinal Study with MR Imaging and Proton Spectroscopy
AJNR Am J Neuroradiol 19:217 221, February 1998 White Matter Disease Induced by High-Dose Chemotherapy: Longitudinal Study with MR Imaging and Proton Spectroscopy Mark S. Brown, Salomon M. Stemmer, Jack
More informationMR spectroscopy in stroke
Dawn E Saunders Department of Radiology, King's College Hospital, London, UK Magnetic resonance spectroscopy (MRS) is a non-invasive in vivo method that allows the investigation of biochemical changes
More informationOriginal Research Article
Original Research Article Comparison of Single Voxel and Multi Voxel Magnetic Resonance Spectroscopy in Evaluation of Brain Tumors Anith Alfred J 1, Abubacker Sulaiman F 2, Divya Shree 3, Ashraf Ahmed
More informationSustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia
Short Communication Journal of NeuroVirology (1998) 4, 95 ± 99 ã 1998 Journal of NeuroVirology, Inc. http://www.jneurovirol.com : relationship to CD4+ cell count, plasma viremia and p24 antigenemia Gerald
More informationBiochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 9854 9859, September 1997 Medical Sciences Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy (AIDS
More informationA Study of N-Acetyl aspartic acid/creatine Ratio in the White Matter of HIV Positive Patients and Its Application
A Study of N-Acetyl aspartic acid/creatine Ratio in the White Matter of HIV Positive Patients and Its Application Vishal Midya 1, Ulhaas Shankar Chakraborty 2 1 Indian Statistical Institute, Delhi, India
More informationORIGINAL CONTRIBUTION. Factors Associated With Incident Human Immunodeficiency Virus Dementia
ORIGINAL CONTRIBUTION Factors Associated With Incident Human Immunodeficiency Virus Dementia Yaakov Stern, PhD; Michael P. McDermott, PhD; Steven Albert, PhD; Donna Palumbo, PhD; Ola A. Selnes, PhD; Justin
More informationA study of the relationship between metabolism using 1 H-MRS and function using several neuropsychological
Seizure 2001; 10: 188 193 doi:10.1053/seiz.2000.0498, available online at http://www.idealibrary.com on A study of the relationship between metabolism using 1 H-MRS and function using several neuropsychological
More informationMagnetization Transfer Ratio Values and Proton MR Spectroscopy of Normal-appearing Cerebral White Matter in Patients with Liver Cirrhosis
AJNR Am J Neuroradiol 22:1137 1142, June/July 2001 Magnetization Transfer Ratio Values and Proton MR Spectroscopy of Normal-appearing Cerebral White Matter in Patients with Liver Cirrhosis Alex Rovira,
More informationImaging is routinely used for the
Magnetic resonance spectroscopy of the brain Ajay Kumar Singh, MD; Ay-Ming Wang, MD; William Sanders, MD In vivo magnetic resonance (MR) spectroscopy is a noninvasive imaging modality useful for obtaining
More informationThe prevalence of HIV-associated neurocognitive
The authors investigated the combined age and HIV effects on cognitive functions in 146 individuals, 116 of whom had HIV infection. Fortytwo percent had HIV-associated neurocognitive disorder, and all
More informationThe Role of Cardiovascular Risk and Aging in Memory Performance in a Sample of Veterans with HIV
The Role of Cardiovascular Risk and Aging in Memory Performance in a Sample of Veterans with HIV LYNN KAKOS, PH.D. VA MARYLAND HEALTH CARE SYSTEM (VAMHCS) OBJECTIVES HIV in the VA Neurocognitive profile
More informationCorrelation of quantitative proton MR spectroscopy with local histology from stereotactic brain biopsy to evaluate heterogeneity of brain tumors
Correlation of quantitative proton MR spectroscopy with local histology from stereotactic brain biopsy to evaluate heterogeneity of brain tumors Steve H. Fung, MD 1, Edward F. Jackson, PhD 2, Samuel J.
More informationAbnormally High Levels of Brain N-Acetylaspartate in Children with Sickle Cell Disease
AJNR Am J Neuroradiol 26:463 468, March 2005 Abnormally High Levels of Brain N-Acetylaspartate in Children with Sickle Cell Disease R. Grant Steen and Robert J. Ogg BACKGROUND AND PURPOSE: The most abundant
More informationApproach to HIV Associated Neurocognitive disorders (HAND)
Approach to HIV Associated Neurocognitive disorders (HAND) Dinesh Singh MB ChB (Natal), M Med (Psych) (Natal), F CPsych (SA), MS (epi) (Columbia, USA), PhD (candidate UKZN) 2 October 2009 ICC, Durban Overview
More informationLaura Tormoehlen, M.D. Neurology and EM-Toxicology Indiana University
Laura Tormoehlen, M.D. Neurology and EM-Toxicology Indiana University Disclosures! No conflicts of interest to disclose Neuroimaging 101! Plain films! Computed tomography " Angiography " Perfusion! Magnetic
More informationCOGNITIVE DYSFUNCTION AMONG HIV-POSITIVE PATIENTS ATTENDING CCC AT KENYATTA NATIONAL HOSPITAL
COGNITIVE DYSFUNCTION AMONG HIV-POSITIVE PATIENTS ATTENDING CCC AT KENYATTA NATIONAL HOSPITAL Principal Investigator Dr. Zaheer Bagha Supervisors Prof. E. Amayo Prof. A. M. Adam Dr. J. O. Mecha INTRODUCTION
More informationIn Vivo Proton MR Spectroscopy of Untreated and Treated Brain Abscesses
AJNR Am J Neuroradiol 20:1049 1053, June/July 1999 Case Report In Vivo Proton MR Spectroscopy of Untreated and Treated Brain Abscesses Isabella M. Burtscher and Stig Holtås Summary: MR spectroscopy was
More informationKey Words: Parkinson's disease, Magnetic resonance spectroscopy (MRS) 대한신경과학회지 21 권 6 호
Jong-Ki Kim,.D., Byeong-Chae Kim,.D., Kee-Ra Lee,.D., in-kyung Song,.D., an-seok Park,.D., yeong-kyu Kim,.D., Ki-Hyun Cho,.D., Jeong-Jin Seo,.D. Background: Parkinson's disease is a progressive, common
More informationHigh-resolution T 2 -reversed magnetic resonance imaging on a high-magnetic field system Technical note
High-resolution T 2 -reversed magnetic resonance imaging on a high-magnetic field system Technical note Yukihiko Fujii, M.D., Ph.D., Naoki Nakayama, M.D., and Tsutomu Nakada, M.D., Ph.D. Departments of
More informationHIV Neurology Persistence of Cognitive Impairment Despite cart
HIV Neurology Persistence of Cognitive Impairment Despite cart Victor Valcour MD PhD Professor of Medicine Memory and Aging Center, Dept. of Neurology University of California San Francisco, USA 8 th International
More informationThe Relationship Between Age and Cognitive Function in HIV-Infected Men
The Relationship Between Age and Cognitive Function in HIV-Infected en Emily C. Kissel Nicole D. Pukay-artin, B.A. Robert A. Bornstein, Ph.D. Several studies have identified increased age as a risk factor
More informationInternational Symposium on. Barcelona, May 5 th and 6 th 2011
th International Symposium on Barcelona, May 5 th and 6 th 2011 4rd Symposium on Psychiatry and HIV --- Barcelona, May 6th 2010 Neurocognitive Testing in HIV Infection: How to Implement this Assessment
More informationMuch clinical and basic science evidence indicates
Spatial Working Memory in Asymptomatic HIV-Infected Many clinical and research findings converge to indicate that frontal lobe, basal ganglia, and related neuronal connections are primarily involved in
More informationMR spectroscopy in diagnosing intracranial lesions: comparison of diagnostic accuracy at different TE
MR spectroscopy in diagnosing intracranial lesions: comparison of diagnostic accuracy at different TE Poster No.: C-1359 Congress: ECR 2013 Type: Authors: Keywords: DOI: Scientific Exhibit A. S. DUNGDUNG;
More informationCorresponding author: A.D. Xu
Study of white matter at the centrum semiovale level with magnetic resonance spectroscopy and diffusion tensor imaging in cerebral small vessel disease L.A. Huang 1, X.Y. Ling 2, C. Li 2, S.J. Zhang 1,
More informationVisualization strategies for major white matter tracts identified by diffusion tensor imaging for intraoperative use
International Congress Series 1281 (2005) 793 797 www.ics-elsevier.com Visualization strategies for major white matter tracts identified by diffusion tensor imaging for intraoperative use Ch. Nimsky a,b,
More informationHypothalamic hamartomas are non-neoplastic congenital
ORIGINAL RESEARCH D.R. Amstutz S.W. Coons J.F. Kerrigan H.L. Rekate J.E. Heiserman Hypothalamic Hamartomas: Correlation of MR Imaging and Spectroscopic Findings with Tumor Glial Content BACKGROUND AND
More informationValue of Single-Voxel Proton MR Spectroscopy in Temporal Lobe Epilepsy
Value of Single-Voxel Proton MR Spectroscopy in Temporal Lobe Epilepsy Eric Achten, Paul Boon, Tom Van De Kerckhove, Jacques Caemaert, Jacques De Reuck, and Marc Kunnen PURPOSE: To study the value of different
More informationUniversity of Groningen. Fluoxetine as disease modifying treatment in multiple sclerosis Mostert, Jop Pieter
University of Groningen Fluoxetine as disease modifying treatment in multiple sclerosis Mostert, Jop Pieter IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish
More informationElevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients
Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients D.J. Meyerhoff, Dr.rer.nat.; C. Bloomer, BA; V. Cardenas, PhD; D. Norman, MD; M.W. Weiner, MD; and G. Fein,
More informationDISTINCTION BETWEEN RECURRENT GLIOMA AND RADIATION INJURY USING MAGNETIC RESONANCE SPECTROSCOPY IN COMBINATION WITH DIFFUSION-WEIGHTED IMAGING
doi:10.1016/j.ijrobp.2006.12.001 Int. J. Radiation Oncology Biol. Phys., Vol. 68, No. 1, pp. 151 158, 2007 Copyright 2007 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/07/$ see front
More informationAmyotrophic lateral sclerosis (ALS) is a motor neuron disease
ORIGINL RESERCH S. Ngai Y.M. Tang L. Du S. Stuckey Hyperintensity of the Precentral Gyral Subcortical White Matter and Hypointensity of the Precentral Gyrus on Fluid-ttenuated Inversion Recovery: Variation
More informationClinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B.
UvA-DARE (Digital Academic Repository) Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B. Link to publication Citation for published version (APA): Post, B. (2009). Clinimetrics,
More informationBrain tissue and white matter lesion volume analysis in diabetes mellitus type 2
Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2 C. Jongen J. van der Grond L.J. Kappelle G.J. Biessels M.A. Viergever J.P.W. Pluim On behalf of the Utrecht Diabetic Encephalopathy
More informationOriginal Article Hippocampal MR spectroscopic abnormalities in a cohort of syphilitic patients with HIV and neurosyphilis infection
Am J Nucl Med Mol Imaging 2015;5(1):83-94 www.ajnmmi.us /ISSN:2160-8407/ajnmmi0001903 Original Article Hippocampal MR spectroscopic abnormalities in a cohort of syphilitic patients with HIV and neurosyphilis
More information1) Diffusion weighted imaging DWI is a term used to describe moving molecules due to random thermal motion. This motion is restricted by boundaries
1) Diffusion weighted imaging DWI is a term used to describe moving molecules due to random thermal motion. This motion is restricted by boundaries such as ligaments, membranes and macro molecules. Diffusion
More informationThe Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University
The Neurology of HIV Infection Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University HIV/AIDS Epidemiology World-wide pandemic, 40 million affected U.S.- Disproportionate
More informationMagnetic Resonance Spectroscopic Findings of Chronic Lesions in Two Subtypes of Multiple Sclerosis: Primary Progressive Versus Relapsing Remitting
Iranian Journal of Radiology. 2013 September; 10(3): 128-32. Published Online 2013 August 30. NEURORADIOLOGY 10.5812/iranjradiol.11336 Research Article Magnetic Resonance Spectroscopic Findings of Chronic
More informationMagnetization Transfer Study of HIV Encephalitis and Progressive Multifocal Leukoencephalopathy
Magnetization Transfer Study of HIV Encephalitis and Progressive Multifocal Leukoencephalopathy Vincent Dousset, Jean-Pierre Armand, Denis Lacoste, Stéphane Mièze, Luc Letenneur, Jean-François Dartigues,
More informationMarchiafava-Bignami Disease: Longitudinal MR Imaging and MR Spectroscopy Study
AJNR Am J Neuroradiol 24:249 253, February 2003 Case Report Marchiafava-Bignami Disease: Longitudinal MR Imaging and MR Spectroscopy Study Anna Gambini, Andrea Falini, Lucia Moiola, Giancarlo Comi, and
More informationDynamic 1H-MRS assessment of brain tumors: A novel approach for differential diagnosis of glioma
Dynamic 1H-MRS assessment of brain tumors: A novel approach for differential diagnosis of glioma The Harvard community has made this article openly available. Please share how this access benefits you.
More informationSupplementary Online Content
Supplementary Online Content Gregg NM, Kim AE, Gurol ME, et al. Incidental cerebral microbleeds and cerebral blood flow in elderly individuals. JAMA Neurol. Published online July 13, 2015. doi:10.1001/jamaneurol.2015.1359.
More informationfmri and Voxel-based Morphometry in Detection of Early Stages of Alzheimer's Disease
fmri and Voxel-based Morphometry in Detection of Early Stages of Alzheimer's Disease Andrey V. Sokolov 1,3, Sergey V. Vorobyev 2, Aleksandr Yu. Efimtcev 1,3, Viacheslav S. Dekan 1,3, Gennadiy E. Trufanov
More informationFUNCTIONAL MAGNETIC RESONANCE IMAGING IN FOLLOW-UP OF CEREBRAL GLIAL TUMORS
Anvita Bieza FUNCTIONAL MAGNETIC RESONANCE IMAGING IN FOLLOW-UP OF CEREBRAL GLIAL TUMORS Summary of Doctoral Thesis to obtain PhD degree in medicine Specialty Diagnostic Radiology Riga, 2013 Doctoral thesis
More informationDiffusion-Weighted and Conventional MR Imaging Findings of Neuroaxonal Dystrophy
AJNR Am J Neuroradiol 25:1269 1273, August 2004 Diffusion-Weighted and Conventional MR Imaging Findings of Neuroaxonal Dystrophy R. Nuri Sener BACKGROUND AND PURPOSE: Neuroaxonal dystrophy is a rare progressive
More informationIncidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)
376 Neurology, University Clinic Essen, Hufelandstrasse 55, 45122 Essen, Germany M Maschke O Kastrup A Hufnagel Dermatology S Esser U Hengge Internal Medicine B Ross Correspondence to: Dr Matthias Maschke
More informationFunctional Magnetic Resonance Imaging with Arterial Spin Labeling: Techniques and Potential Clinical and Research Applications
pissn 2384-1095 eissn 2384-1109 imri 2017;21:91-96 https://doi.org/10.13104/imri.2017.21.2.91 Functional Magnetic Resonance Imaging with Arterial Spin Labeling: Techniques and Potential Clinical and Research
More informationOriginal Articles. Calne, resting tremor. Mortimer, Pirozzolo, Hansch, & Webster, postural disturbance III
2004 97-106 Original Articles 1 2 3 1 1 2 3 47 22 III I II muscular rigidity postural disturbance resting tremor bradykinesia Calne, 2001 Mortimer, Pirozzolo, Hansch, & Webster, 1982 Tel: 02-23627076 E-mail:
More informationSupplementary Online Content
Supplementary Online Content Schlaeger R, Papinutto N, Zhu AH, et al. Association between thoracic spinal cord gray matter atrophy and disability in multiple sclerosis. JAMA Neurol. Published online June
More informationFunctional MR Spectroscopy of the Auditory Cortex in Healthy Subjects and Patients with Sudden Hearing Loss
Functional MR Spectroscopy of the Auditory Cortex in Healthy Subjects and Patients with Sudden Hearing Loss T. L. Richards, G. A. Gates, J. C. Gardner, T. Merrill, C. E. Hayes, H. Panagiotides, S. Serafini,
More informationNeurometabolism of Active Neuropsychiatric Lupus Determined with Proton MR Spectroscopy
Neurometabolism of Active Neuropsychiatric Lupus Determined with Proton MR Spectroscopy Wilmer L. Sibbitt, Jr, Luke J. Haseler, Richard R. Griffey, Seth D. Friedman, and William M. Brooks PURPOSE: To determine
More informationCortical hypoperfusion in Parkinson's disease assessed with arterial spin labeling MRI
Cortical hypoperfusion in Parkinson's disease assessed with arterial spin labeling MRI Poster No.: C-0609 Congress: ECR 2013 Type: Scientific Exhibit Authors: S. Aoki, K. Kamagata, Y. Motoi, K. Kamiya,
More informationStructural Changes of the Substantia Nigra in Parkinson s Disease as Revealed by MR Imaging
AJNR Am J Neuroradiol 21:697 701, April 2000 Structural Changes of the Substantia Nigra in Parkinson s Disease as Revealed by MR Imaging Michael Hutchinson and Ulrich Raff BACKGROUND AND PURPOSE: The possibility
More informationBrainProtonMagnetic Resonance Spectroscopy Introduction and Overview
BrainProtonMagnetic Resonance Spectroscopy Introduction and Overview Débora Bertholdo, MD, Arvemas Watcharakorn, MD, Mauricio Castillo, MD* KEYWORDS 1 H Magnetic resonance spectroscopy Stimulated echo
More informationProton MR Spectroscopy of Delayed Cerebral Radiation in Monkeys and Humans after Brachytherapy
Proton MR Spectroscopy of Delayed Cerebral Radiation in Monkeys and Humans after Brachytherapy Kimihisa Kinoshita, Eiji Tada, Kengo Matsumoto, Shoji Asari, Takashi Ohmoto, and Takahiko Itoh PURPOSE: To
More informationThe Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord
The Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord Mark D. Keiper, Robert I. Grossman, John C. Brunson, and Mitchell D. Schnall PURPOSE:
More informationMRIofthe Central Nervous System
K. Mori (Ed.) MRIofthe Central Nervous System A Pathology Atlas With the Collaboration of M. Kurisaka A. Moriki A. Sawada With 116 Case Studies and 372 Figures Springer-Verlag Tokyo Berlin Heidelberg New
More informationImaging in Pediatric `neurohiv Dr Jackie Hoare Head of Liaison Psychiatry Groote Schuur Hospital, UCT
Imaging in Pediatric `neurohiv Dr Jackie Hoare Head of Liaison Psychiatry Groote Schuur Hospital, UCT ? Spectrum of Neurocognitive disorders The adult literature on HIV related CNS damage supports a spectrum
More informationSUPPLEMENTARY INFORMATION In format provided by Frank et al. (JULY 2010)
Table 1 Imaging bios for Alzheimer s Visual rating High correlation with Multicenter studies have Accuracy for longitudinal hippocampus volume (R 2 been performed, but changes only at chance about 0.9,
More informationHow good is MRI at elucidating evolving HIV neuropathogenesis? Research and clinical implications
HIV Endgame I: Closing Gaps in the Care Cascade, October 26tth, 2016 Toronto, Canada OHTN/ISNV How good is MRI at elucidating evolving HIV neuropathogenesis? Research and clinical implications Lucette
More informationStructural and functional imaging for the characterization of CNS lymphomas
Structural and functional imaging for the characterization of CNS lymphomas Cristina Besada Introduction A few decades ago, Primary Central Nervous System Lymphoma (PCNSL) was considered as an extremely
More informationThe diffusion-weighted imaging (DWI) MR sequence showed an hyposignal of the lesion eliminating a cerebral pyogenic abscess which usually presents an
Cerebral toxoplasmosis is one of the most common opportunistic neurological infections in AIDS patients, and is typically observed in the later stages of human immunodeficiency virus (HIV) infection. 1,2
More informationProton MR Spectroscopic Characteristics of Pediatric Pilocytic Astrocytomas
AJNR Am J Neuroradiol 19:535 540, March 1998 Proton MR Spectroscopic Characteristics of Pediatric Pilocytic Astrocytomas Jong-Hee Hwang, Greg F. Egnaczyk, Edgar Ballard, R. Scott Dunn, Scott K. Holland,
More informationFat Suppression in the Abdomen
Clinical How I do it? Fat Suppression in the Abdomen Wilhelm Horger Siemens Medical Solutions, Erlangen, Germany Introduction Due to the different chemical environment, hydrogen nuclei in - and in -tissue
More informationSHORTLY AFTER ITS FIRST DEpiction
OBSERVATION Seven-Tesla Magnetic Resonance Imaging New Vision of Microvascular Abnormalities in Multiple Sclerosis Yulin Ge, MD; Vahe M. Zohrabian, MD; Robert I. Grossman, MD Background: Although the role
More informationRadiation-Induced Brain Metabolic Changes in the Acute and Early Delayed Phase Detected With Quantitative Proton Magnetic Resonance Spectroscopy
ORIGINAL ARTICLE Radiation-Induced Brain Metabolic Changes in the Acute and Early Delayed Phase Detected With Quantitative Proton Magnetic Resonance Spectroscopy Tatsuro Kaminaga, MD and Katsuo Shirai,
More informationPrimary Central Nervous System Lymphoma with Lateral Ventricle Involvement
The Open Medical Imaging Journal, 2012, 6, 103-107 103 Open Access Primary Central Nervous System Lymphoma with Lateral Ventricle Involvement Yumi Oie 1,*, Kazuhiro Murayama 1, Shinya Nagahisa 2, Masato
More informationNeuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies
Neuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies Principal Investigator: Dr. Donatella Tampieri, MD, FRCPC, Department of Neuroradiology, Montreal
More informationSupplementary information Detailed Materials and Methods
Supplementary information Detailed Materials and Methods Subjects The experiment included twelve subjects: ten sighted subjects and two blind. Five of the ten sighted subjects were expert users of a visual-to-auditory
More informationHAND is Common and Important in Patients on ART
HAND is Common and Important in Patients on ART Igor Grant, MD, FRCP(C) Director HIV Neurobehavioral Research Program University of California, San Diego How is HAND diagnosed? How prevalent is it? Points
More informationAssessment of Gliomatosis Cerebri
MRS of Gliomatosis Cerebri Neuroradiology Original Research Juan A. Guzmán-de-Villoria 1 Javier Sánchez-González 2 Lucia Muñoz 1 Santiago Reig 2 Carlos Benito 3 Pedro García-Barreno 2 Manuel Desco 2 Guzmán-de-Villoria
More information